Arthur A Levin sold $233k of RNA
director at Avidity Biosciences, Inc.. 5,000 shares at an average of $46.63, traded Oct 21, 2024, filed Oct 23, 2024.
Score components
- +15RoleDirector
- +13Trade size$233k at market
- +10Share of holdings soldSold 25% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001599901-24-000172, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 21, 2024 | MOption exercise Common Stock10b5-1 | +5,000 | $1.24 | $6,200 | 19,830 | Oct 23, 2024 |
| Oct 21, 2024 | SOpen-market sale Common Stock10b5-1 | -5,000 | $46.63 | $233k | 14,830 | Oct 23, 2024 |
| Oct 21, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 3,323 | Oct 23, 2024 |
Related signals
Other insiders at Avidity Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Avidity Biosciences, Inc. | Steven George Hughes Chief Medical Officer | $105k 2,209 shares | -5% | |
| 25Weak | Avidity Biosciences, Inc. | Teresa McCarthy Chief Human Resources Officer | $1.0M 20,000 shares | -17% | |
| 14Weak | Avidity Biosciences, Inc. | Eric Mosbrooker Chief Commercial Officer | $298k 6,562 shares | -11% | |
| 4Weak | Avidity Biosciences, Inc. | Steven George Hughes Chief Medical Officer | $90k 2,208 shares | -5% | |
| 3Weak | Avidity Biosciences, Inc. | Steven George Hughes Chief Medical Officer | $70k 1,542 shares | -4% | |
| 20Weak | Avidity Biosciences, Inc. | Teresa McCarthy Chief Human Resources Officer | $621k 15,000 shares | -13% | |
| 22Weak | Avidity Biosciences, Inc. | W. Michael Flanagan Chief Scientific Officer | $779k 20,000 shares | -20% | |
| 30Weak | Avidity Biosciences, Inc. | Troy Edward Wilson director | $1.5M 29,500 shares | -35% | |
| 14Weak | Avidity Biosciences, Inc. | Eric Mosbrooker Chief Commercial Officer | $309k 6,563 shares | -11% | |
| 35Weak | Avidity Biosciences, Inc. | Sarah Boyce President and CEO | $2.5M 50,000 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.